NF2 and schwannoma: However, the loss of the wild-type SMARCB1 allele is insufficient for schwannoma growth which appears to be dependent upon concomitant somatic NF2 PVs in patients with SMARCB1-related schwannomatosis according to the four-hit/three-step model of tumorigenesis.